Ikena Oncology Inc (IKNA) Company Profile & Statistics

Ikena Oncology Inc
IKNA
(Nasdaq - US)
Open
1.72
+0.02 (+0.88%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
1.72
High
1.75
Low
1.71

About Ikena Oncology Inc

CEO

Mark Manfredi

Headquarters

645 summer street, suite 101

boston, ma 02210, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.ikenaoncology.com

Industry

biotechnology

Sector

health technology

Company Overview

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.

Ikena Oncology Inc Statistics

Valuation Measures

Market Capitalization ²	82.77M
Enterprise Value	37.58M
Enterprise Value/EBITDA (ttm)	-0.54
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.60
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-740.46%
Return on Equity (ttm)	-36.88%
Return on Invested Capital (ttm)	-39.11%
Return on Assets (ttm)	-33.08%

Income Statement

Revenue (ttm)	658.00K
Revenue Per Share (ttm)	0.01
Gross Profit (ttm)	658.00K
EBITDA (ttm)³	-69.16M
Net Income Avi to Common (ttm)	-59.60M
Diluted EPS (ttm)	-1.23

Share Statistics

Beta (5Y Monthly)	0.48
52-Week Change	0.29%
S&P500 52-Week Change	31.01%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	48.26M
Dividend Yield	0.00%
Float ⁴	45.39M
% Held by Insiders	5.94%
% Held by Institutions	75.00%

Balance Sheet

Total Cash (mrq)	138.03M
Total Cash Per Share (mrq)	2.86
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	15.32%
Quick Ratio (mrq)	15.32%
Book Value Per Share (mrq)	2.78

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.82
Free Cash Flow (ytd)	-39.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ikena Oncology Inc

Trade With A Regulated Broker